Jin and Haoyi Sun of Zhong Lun Law Firm discuss the reasons behind, and the implications of, Illumina’s inclusion in China’s ...

Ultima Genomics announces that it will provide three trillion DNA sequencing reads free of charge to researchers across the ...

Illumina expects to reach a growth rate in its revenues of 6%-9% CAGR by 2027. See why I think ILMN stock is an appealing ...

Keith Meister, Corvex Management's chief investment officer, will join Illumina's board starting March 28. He's no stranger to the world of biotech.

Activist investor Keith Meister will join the board of gene-sequencing maker Illumina , and current board member Scott ...

Keith Meister’s hedge fund Corvex Management has a 2.5% stake in the gene-sequencing machine maker.

The genetic sequencing market could grow to $75 billion by 2033. Illumina ranks as the largest player in genetic sequencing. Other top genetic sequencing companies include PacBio, 10X Genomics ...

Illumina (ILMN) stock rises as activist investor Keith Meister joins the board, with Scott Gottlieb named chairman. Read more ...

At the same time, Keith Meister, managing partner and chief investment officer of the hedge fund Corvex Management, will take ...

Struggling gene-sequencing machine and chemical company Illumina (ILMN) has fallen further into the hands of activist investors. Keith ...

Futurewise Research, a leading market intelligence firm, has released an in-depth market report on the Immune Repertoire ...

The firm's next-generation sequencing-based test detects single nucleotide variants, insertions, and deletions in 22 genes.